Back to results
Recruiting

The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

NCT03878706

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

"Attikon" University General Hospital

Athens, Attica, Greece

Contact

Ignatios Ikonomidis, Prof.

00306944805732ignoik@gmail.com
View on ClinicalTrials.gov
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination — TrialFind